major side effects of semaglutide What to Expect After First Injection: Complete Guide Exploring the Side Effects of

Semaglutide has an equivalent non-invasive option that does not carry similar risks, with close outcomes without the invasive potential complications

F.et al (2020)

Not catastrophic, but worth noting

AEs leading to trial product discontinuation occurred in 51/603 (8.5%) participants in the CagriSema 2.4 mg/2.4 mg group, 40/605 (6.6%) participants in the semaglutide 2.4 mg group, 7/152 (4.6%) participants in the cagrilintide 2.4 mg group, 42/594 (7.1%) participants in the CagriSema 1 mg/1 mg group, 26/608 (4.3%) participants in the semaglutide 1 mg group, and 2/149 (1.3%) participants in the placebo group

So far, no compounding pharmacy has been fined or lost their license in Louisiana and Mississippi, according to state regulators